The move to remote working necessitated by the pandemic may help the US Food and Drug Administration retain senior staff who would otherwise retire, Center for Biologics Evaluation and Research Director Peter Marks noted.
Speaking at the 12 September opening plenary of the Regulatory Affairs Professional Society’s (RAPS) Convergence meeting, Marks said he has...






